Form 4: Hinge Health Co-Founder Executes Planned Stock Sale

Executive Chairman Gabriel Mecklenburg sold 50,000 shares of Hinge Health Class A Common Stock via a Rule 10b5-1 trading plan.

Summary

• Gabriel Mecklenburg, Executive Chairman and Co-Founder of Hinge Health, converted 50,000 shares of Class B Common Stock into Class A Common Stock.
• Following the conversion, the reporting person sold all 50,000 shares of Class A Common Stock at a weighted average price of $55.0087 per share.
• The transaction was executed on May 6, 2026, pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025.
• The sale resulted in zero direct beneficial ownership of Class A Common Stock for the reporting person following the transaction.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted through a pre-established 10b5-1 plan, which is a standard and transparent method for insider liquidity.

Positives

• The transaction was pre-planned under a Rule 10b5-1 trading plan, which is a standard mechanism for insiders to sell stock without triggering concerns regarding non-public information.

Negatives

• The sale represents a divestment of 50,000 shares by a key executive and co-founder.

Risks

• Continued reliance on Rule 10b5-1 plans for liquidity may signal ongoing divestment by company leadership.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a common practice for executives to manage personal liquidity and is generally viewed as neutral by the market when pre-arranged.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate executives to conduct orderly divestments while maintaining compliance with SEC regulations.

Related Party Transactions

• The filing notes the transfer of 234,239 shares of Class B Common Stock to the reporting person from a Grantor Retained Annuity Trust (GRAT) effective May 6, 2026.

Stakeholder Impact

• Shareholders should note the reduction in direct holdings by the Executive Chairman, though the pre-planned nature mitigates negative sentiment.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Hinge Health, HNGE, Insider Trading, Form 4, Rule 10b5-1, Executive Compensation